• 1. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 2. Aggregation-induced emission leading to two distinct emissive species in the solid-state structure of high-dipole organic chromophores?
  Felix Witte,Philipp Rietsch,Nithiya Nirmalananthan-Budau,Florian Weigert,Jan P. G?tze,Ute Resch-Genger,Siegfried Eigler,Beate Paulus Phys. Chem. Chem. Phys., 2021,23, 17521-17529
• 3. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

1-(2-Amino-4-Fluorophenyl)ethan-1-one (CAS No. 159305-15-4): An Overview and Recent Advances

1-(2-Amino-4-fluorophenyl)ethan-1-one (CAS No. 159305-15-4) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 4-fluoroacetanilide, is characterized by its unique structural features, which include an amino group and a fluorine atom substituted on a phenyl ring, along with an acetone moiety. These structural elements contribute to its diverse chemical and biological properties, making it a valuable candidate for various applications.

The chemical structure of 1-(2-amino-4-fluorophenyl)ethan-1-one consists of a phenyl ring with an amino group at the 2-position and a fluorine atom at the 4-position, attached to an acetone group. This arrangement provides the compound with both electron-donating and electron-withdrawing functionalities, which can influence its reactivity and biological activity. The presence of the fluorine atom, in particular, can enhance the compound's metabolic stability and improve its pharmacokinetic properties.

In recent years, 1-(2-amino-4-fluorophenyl)ethan-1-one has been extensively studied for its potential therapeutic applications. One of the key areas of interest is its role as a lead compound in the development of new drugs for various diseases. For instance, researchers have explored its potential as an antibacterial agent, particularly against multidrug-resistant bacteria. Studies have shown that this compound can effectively inhibit bacterial growth by disrupting essential cellular processes, making it a promising candidate for the development of novel antibiotics.

Beyond its antibacterial properties, 1-(2-amino-4-fluorophenyl)ethan-1-one has also been investigated for its antiviral activity. Recent studies have demonstrated that this compound can inhibit the replication of several viruses, including influenza and herpes simplex virus (HSV). The mechanism of action involves interfering with viral entry into host cells and blocking viral replication pathways. These findings suggest that 1-(2-amino-4-fluorophenyl)ethan-1-one could be developed into a broad-spectrum antiviral agent.

In addition to its antimicrobial properties, 1-(2-amino-4-fluorophenyl)ethan-1-one has shown potential in the treatment of neurodegenerative diseases. Research has indicated that this compound can modulate specific neurotransmitter systems and protect neurons from oxidative stress and inflammation. For example, studies have shown that it can reduce the accumulation of beta-amyloid plaques in Alzheimer's disease models, suggesting its potential as a therapeutic agent for neurodegenerative disorders.

The pharmacological profile of 1-(2-amino-4-fluorophenyl)ethan-1-one has also been extensively characterized. Preclinical studies have demonstrated that this compound exhibits favorable pharmacokinetic properties, including good oral bioavailability and low toxicity. These attributes make it an attractive candidate for further development into clinical trials. Moreover, its ability to cross the blood-brain barrier (BBB) is particularly noteworthy for applications in central nervous system (CNS) disorders.

Recent advancements in synthetic chemistry have also contributed to the development of more efficient methods for producing 1-(2-amino-4-fluorophenyl)ethan-1-one. Novel synthetic routes have been reported that improve yield and reduce production costs, making it more accessible for large-scale applications. These advancements are crucial for translating laboratory findings into practical therapeutic solutions.

Despite its promising potential, further research is needed to fully understand the mechanisms of action and optimize the therapeutic efficacy of 1-(2-amino-4-fluorophenyl)ethan-1-one. Ongoing studies are focusing on identifying specific molecular targets and elucidating the signaling pathways involved in its biological effects. Additionally, efforts are being made to develop derivative compounds with enhanced potency and selectivity.

In conclusion, 1-(2-amino-4-fluorophenyl)ethan-1-one (CAS No. 159305-15-4) is a multifaceted compound with significant potential in various therapeutic areas. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for drug development. As research continues to advance, it is likely that this compound will play an increasingly important role in addressing unmet medical needs.

• 124958-64-1(Ethanone, 1-[4-fluoro-2-(methylamino)phenyl]- (9CI))
• 728024-64-4(1-(2-Amino-5-fluoro-phenyl)-2-phenyl-ethanone)
• 91713-56-3(Methanone, (2-amino-5-methylphenyl)(4-fluorophenyl)-)
• 2343-25-1(1-(2-amino-5-fluoro-phenyl)ethanone)
• 869937-08-6(1-(2-Amino-6-fluorophenyl)ethanone)
• 124623-14-9(1-(2-Amino-5-fluorophenyl)propan-1-one)
• 3800-06-4(2-Amino-4'-fluorobenzophenone)
• 124623-26-3(1-(2-amino-3-fluorophenyl)ethan-1-one)
• 782-01-4(Methanone, (2-aminophenyl)(3-fluorophenyl)-)
• 362-46-9(2-Amino-5-fluorobenzophenone)